In addition, comparison of data from matched adjacent benign colorectal tissues and CRC patient tissues from both GSE32323 and TCGA revealed higher SLC2A3 mRNA levels, while only CRC tissue data from the TCGA showed increased SLC2A1 mRNA levels (Fig. 1b, c and Supplementary Fig. S1d–i). The gene discussed is SLC2A1; the disease is colorectal carcinoma.